We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 157

European Commission proposes new competition law private damages action and collective redress legislation
  • Wragge Lawrence Graham & Co LLP
  • European Union
  • June 11 2013

Today, the European Commission (Commission) has adopted legislative proposals for private antitrust damages actions and collective redress, along


Case C-23406 P-II Ponte Finanziaria SpA - minimum threshold of similarity between marks
  • Wragge Lawrence Graham & Co LLP
  • European Union, Italy
  • October 31 2007

The ECJ has lent support to the notion that there is a minimum threshold of similarity between marks that needs to be established before there is any need to consider the principle of interdependence as part of the likelihood of confusion assessment


The European Parliament votes through cyber security legislation
  • Wragge Lawrence Graham & Co LLP
  • European Union
  • April 14 2014

In February 2013, the European Commission released a draft Network and Information Security Directive (the Draft Directive). In addition to


The scope of the DNA patents - ECJ's decision in Monsanto v Cefetra
  • Wragge Lawrence Graham & Co LLP
  • European Union
  • July 7 2010

The Court of Justice of the European Union (CJEU) has handed down its decision on the scope of protection to be afforded to DNA sequence patents


Alternative Investment Fund Managers Directive - after a long battle it is finally agreed
  • Wragge Lawrence Graham & Co LLP
  • European Union
  • November 12 2010

The European Parliament resolved to approve the final version of the Alternative Investment Fund Managers Directive yesterday


Patent law proposals to bring clinical trials back to the UK
  • Wragge Lawrence Graham & Co LLP
  • European Union, United Kingdom
  • May 9 2014

New patent law proposals laid in Parliament earlier this week could result in clinical trials being brought back to the UK. Wragge Lawrence Graham &


Latest update on the European Commission's investigation into possible state aid for the Hinkley Point nuclear new build project
  • Wragge Lawrence Graham & Co LLP
  • European Union, United Kingdom
  • March 6 2014

On 18 December 2013, the European Commission decided to investigate alleged state aid by the UK into the nuclear new build project at Hinkley point


Subject-matter, scope and second medical use - defining double-patenting
  • Wragge Lawrence Graham & Co LLP
  • European Union
  • May 21 2014

On 12 July 1999, The Board of Regents of the University of Texas System (UTS) made an application (application number 99940802.4) for a patent


ESMA publish Q&A regarding the application of the AIFMD
  • Wragge Lawrence Graham & Co LLP
  • European Union
  • March 10 2014

In February 2014, the European Securities and Markets Authority (ESMA) published a "Questions and Answers" document regarding the application of the


Croatia enters the EU - what it means for IP
  • Wragge Lawrence Graham & Co LLP
  • Croatia, European Union
  • June 20 2013

On 1 July 2013 the European Union will welcome Croatia as its 28th member state. From an intellectual property (IP) perspective, the effect will be